FigureĀ 1.
CONSORT diagram of participant enrollments that underwent adjudication for vaso-occlusive pain. A total of 15 patients were enrolled under the indication of severe vaso-occlusive pain. Two patients failed screening due to investigator decision and the presence of donor-specific antibodies, respectively, and were not reviewed by the adjudication committee. Thirteen were reviewed by the adjudication committee, and 10 were successfully adjudicated and enrolled. A total of 3 patients were deemed ineligible by adjudication.